Lymphosarcoma  >>  cyclosporin A microemulsion  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporin A microemulsion / Generic mfg.
AALL0031, NCT00022737: Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia

Completed
3
220
US
filgrastim, G-CSF, Neupogen, asparaginase, ASNase, Colaspase, Crasnitin, Elspar, L-ASP, cyclophosphamide, CPM, CTX, Cytoxan, Endoxan, Endoxana, cyclosporine, ciclosporin, cyclosporin, cyclosporin A, CYSP, Sandimmune, cytarabine, ARA-C, arabinofuranosylcytosine, arabinosylcytosine, Cytosar-U, cytosine arabinoside, daunorubicin hydrochloride, Cerubidin, Cerubidine, daunomycin hydrochloride, daunorubicin, RP-13057, dexamethasone, Aeroseb-Dex, Decaderm, Decadron, DM, DXM, etoposide, EPEG, VP-16, VP-16-213, ifosfamide, Cyfos, Holoxan, IFF, IFX, IPP, imatinib mesylate, CGP 57148, Gleevec, Glivec, leucovorin calcium, CF, CFR, LV, mercaptopurine tablet, 6-mercaptopurine, 6-MP, Leukerin, MP, methotrexate, amethopterin, Folex, methylaminopterin, Mexate, MTX, pegaspargase, L-asparaginase with polyethylene glycol, Oncaspar, PEG-ASP, PEG-L-asparaginase, vincristine sulfate, leurocristine sulfate, VCR, Vincasar PFS, allogeneic bone marrow transplantation, bone marrow therapy, allogeneic, bone marrow therapy, allogenic, transplantation, allogeneic bone marrow, transplantation, allogenic bone marrow, peripheral blood stem cell transplantation, PBPC transplantation, PBSC transplantation, peripheral blood progenitor cell transplantation, transplantation, peripheral blood stem cell, umbilical cord blood transplantation, cord blood transplantation, transplantation, umbilical cord blood, UCB transplantation, radiation therapy, irradiation, radiotherapy, therapy, radiation
National Cancer Institute (NCI)
Childhood Acute Lymphoblastic Leukemia in Remission, Recurrent Childhood Acute Lymphoblastic Leukemia
10/06
 
NCT00075478: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Completed
3
87
US, Europe
Total-Body Irradiation, TBI, Total Body Irradiation, Whole-Body Irradiation, Fludarabine Phosphate, 2-F-ara-AMP, Beneflur, SH T 586, Mycophenolate Mofetil, Cellcept, MMF, Cyclosporine, 27-400, CsA, Neoral, OL 27-400, Sandimmun, Peripheral Blood Stem Cell Transplantation, PBPC transplantation, Peripheral Blood Progenitor Cell Transplantation, Peripheral Stem Cell Support, Peripheral Stem Cell Transplantation
Fred Hutchinson Cancer Center, National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Hematopoietic and Lymphoid Cell Neoplasm, Indolent Non-Hodgkin Lymphoma, Mantle Cell Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm, Plasma Cell Myeloma, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Waldenstrom Macroglobulinemia
02/14
02/14
NCT00928018: Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma

Completed
3
139
US
Sirolimus, Rapamycin, Methotrexate, Abbreviated MTX, Trade name:Trexall, Tacrolimus, Prograf, Cyclosporine, Brand names:, •Gengraf, •Neoral, •Sandimmune, •Sangcya, MMF, Mycophenolate mofetil (MMF), Brand Names:, CellCept, Myfortic
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital, National Cancer Institute (NCI)
Non-hodgkin Lymphoma, Hodgkin Lymphoma
11/14
11/14
NCT00070187: Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

Completed
2/3
24
US, Canada, RoW
aldesleukin, Proleukin, IL-2, recombinant human Interleukin 2, NSC # 373364, filgrastim, GRANULOCYTE COLONY-STIMULATING FACTOR, r-metHuG-CSF, G-CSF, Neupogen, NSC #614629, recombinant interferon gamma, INTERFERON GAMMA-1b, Actimmune, gamma interferon, immune interferon, lymphocyte interferon, rIFN-gamma, T-interferon, NSC #600662, carmustine, BCNU, BiCNU, bischloronitrosourea, NSC #40996, cyclosporine, cycloporine, Sandimmune, Neoral, Gengraf, NSC #290193, cytarabine, cytosine arabinoside, AraC, Cytosar, NSC #063878, etoposide, VP-16, VePesid, Etopophos, NSC #141540, melphalan, L-PHENYLANINE mustard, L-PAM, L-sarcolysin, Alkeran, NSC #008806, autologous bone marrow transplantation, bone marrow ablation with stem cell support, peripheral blood stem cell transplantation
Children's Oncology Group, National Cancer Institute (NCI)
Lymphoma
06/05
 

Download Options